One Equity Partners, a middle market private equity firm, completed the investment in InfuCare Rx, a comprehensive clinical therapy management services provider. Financial terms were not disclosed. "OEP's investment in InfuCare Rx aligns squarely with our thesis that care will continue to shift towards the lower-cost home setting and our focus on the importance of home-based management of complex chronic conditions. COVID has only accelerated the preference for home-and community-based care delivery; InfuCare Rx is well-positioned to meet this growing demand," Greg Belinfanti, OEP Senior Managing Director.